A Gene Therapy for Resynchronization of Cardiac Conduction in Pacing-Induced Cardiomyopathy
|Title||A Gene Therapy for Resynchronization of Cardiac Conduction in Pacing-Induced Cardiomyopathy|
|Sponsor||Horizon 2020 (H2020)|
|Institution||University of Amsterdam - Academic Medical Center|
Associated cell lines
A first-ever cardiac Gene Therapy Medicinal Product (GTMP) to treat pacing-induced cardiomyopathy (PICM). Our technique involves a proprietary technology to restore ion channels in the heart to generate and resynchronize cardiac pacing function. A GTMP’s safety and efficacy package in line with authorities will allow the compilation and submission of a CTA / IND within 9 months after the project will be concluded.